CollPlant Biotechnologies (CLGN) Gross Profit (2017 - 2025)
CollPlant Biotechnologies (CLGN) reported Gross Profit of -$132000.0 for Q4 2025, down 22.22% on a YoY basis from -$169714.3 in Q4 2024, and up 31.25% quarter-over-quarter from -$192000.0 in Q3 2025.
CollPlant Biotechnologies (CLGN) Gross Profit (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Gross Profit for 9 years, with the latest figure at -$132000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gross Profit fell 22.22% year-over-year to -$132000.0; the trailing twelve-month figure through Dec 2025 stood at -$7.0 billion (down 630391.62% YoY), and the FY2025 full-year result was $1.5 million, up 238.38% from the prior year.
- Gross Profit for Q4 2025 stood at -$132000.0, up from -$192000.0 in the prior quarter.
- The five-year high for Gross Profit was $13.6 million in Q1 2021, with the low at -$7.0 billion in Q2 2025.
- Historically, Gross Profit has averaged -$448.9 million across 5 years, with a median of -$143500.0 in 2022.
- Annual changes were most pronounced in 2021 — Gross Profit tumbled 73882626.78% — and 2023, when it soared 41504.35%.
- CollPlant Biotechnologies' Gross Profit stood at -$238000.0 in 2021, then surged by 98.32% to -$4000.0 in 2022, then slumped by 11750.0% to -$474000.0 in 2023, then soared by 77.22% to -$108000.0 in 2024, then decreased by 22.22% to -$132000.0 in 2025.
- The last three Gross Profit figures came in at -$132000.0 (Q4 2025), -$192000.0 (Q3 2025), and -$7.0 billion (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -132,000.00 |
| Dec 31, 2025 | -132,000.00 |
| Sep 30, 2025 | -192,000.00 |
| Sep 30, 2025 | -192,000.00 |
| Jun 30, 2025 | -7.00 Bn |
| Jun 30, 2025 | -7.00 Bn |
| Mar 31, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | -108,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | -268,000.00 |
| Sep 30, 2024 | -268,000.00 |
| Jun 30, 2024 | -287,000.00 |
| Jun 30, 2024 | -287,000.00 |
| Mar 31, 2024 | -447,000.00 |
| Mar 31, 2024 | -447,000.00 |
| Dec 31, 2023 | -474,000.00 |
| Dec 31, 2023 | -474,000.00 |
| Sep 30, 2023 | -235,000.00 |
| Sep 30, 2023 | -235,000.00 |